Pancreatic Diseases
6 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.
Narrower: Exocrine Pancreatic Insufficiency 1, Pancreatitis 4, Pancreatitis, Acute Necrotizing 1, Pancreatitis, Chronic 1
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| DR10624 Injection for pancreatitis | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Hydrocortisone for pancreatitis | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Pancreatic enzyme capsules for exocrine pancreatic insufficiency | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Pancreatic enzyme capsules for pancreatitis, acute necrotizing | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Soy-tomato juice product + Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed for pancreatitis, chronic | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Trametinib + DABRAFENIB for pancreatic diseases | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.